A Novel 2-Metagene Signature to Identify High-Risk HNSCC Patients amongst Those Who Are Clinically at Intermediate Risk and Are Treated with PORT
一种新型双元基因特征可用于识别接受术后放疗且临床上属于中等风险的头颈部鳞状细胞癌（HNSCC）患者中的高危患者。
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14123031
Patil, Shivaprasad; Linge, Annett; Hiepe, Hannah; Grosser, Marianne; Lohaus, Fabian; Gudziol, Volker; Kemper, Max; Nowak, Alexander; Haim, Dominik; Tinhofer, Inge; Budach, Volker; Guberina, Maja; Stuschke, Martin; Balermpas, Panagiotis; Grün, Jens von der; Schäfer, Henning; Grosu, Anca-Ligia; Abdollahi, Amir; Debus, Jürgen; Ganswindt, Ute; Belka, Claus; Pigorsch, Steffi; Combs, Stephanie E; Boeke, Simon; Zips, Daniel; Jöhrens, Korinna; Baretton, Gustavo B; Baumann, Michael; Krause, Mechthild; Löck, Steffen; On Behalf Of The Dktk-Rog
